News
Bibi Fell invited Dr. Jim Geller out for a drink in San Diego one chilly evening. A year earlier, his pediatric liver team ...
A number of family favourite food items have been revealed to contain harmful additives and chemicals, covered up by the ...
Mycoplasma pneumoniae (M. pneumoniae)-associated community-acquired pneumonia (CAP) incidence was significantly higher in ...
The Arc of Loudoun announced in a July 1 news release that the Ability Fitness Center, a therapeutic fitness and wellness ...
A new study by researchers in the Department of Clinical Neuroscience, Karolinska Institutet, has identified 18 potential ...
Dr. Shelia Swartz shared practical insights into the use of point-of-care ultrasound (POCUS) to enhance pediatric inpatient ...
The U.S. Food and Drug Administration has approved an autoinjector of Benlysta (belimumab) for subcutaneous injection in ...
Alemtuzumab, a humanized monoclonal antibody, shows promise as a disease-modifying therapy for multiple sclerosis. This review examines its safety and efficacy, along with current therapies for MS.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results